Table 2.
Univariate analysis.
| Variable | Good outcome (n = 105), (mean ± SD, n (%)) | Poor outcome (n = 45), (mean ± SD, n (%)) | p-value |
|---|---|---|---|
| Age (years) | 30.9 ± 5.7 | 41.4 ± 6.6 | <0.001 |
| Male sex | 51 (48.6) | 20 (44.4) | 0.643 |
| Prodromal symptoms | 67 (63.8) | 24 (53.3) | 0.229 |
| Psychiatric symptoms | 70 (66.7) | 33 (73.3) | 0.420 |
| Seizures | 60 (57.1) | 29 (64.4) | 0.404 |
| Cognitive impairment | 73 (69.5) | 29 (64.4) | 0.541 |
| Disturbance of consciousness (GCS <8) (%) | 28 (26.7) | 25 (55.5) | <0.001 |
| Movement disorders | 21 (20.0) | 8 (17.8) | 0.752 |
| Mechanical ventilation | 22 (21.0) | 25 (55.5) | <0.001 |
| Tumor present | 14 (13.3) | 15 (33.3) | 0.004 |
| MRI abnormal | 38 (36.2) | 19 (42.2) | 0.486 |
| EEG abnormal | 68 (64.8) | 27 (60.0) | 0.579 |
| Anti-NMDA | 45 (42.9) | 18 (40.0) | 0.745 |